SHAHEEN CHOWDHRY: Open Payments
NPI 1104815463 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 54 payments from 19 companies in 2025. Trend: 2023 $1,497 · 2024 $1,667 · 2025 $1,513
Food & beverage: $1,513
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $273 |
| Amgen Inc. | 13 | $172 |
| Actelion Pharmaceuticals US, Inc. | 6 | $162 |
| ABIOMED | 1 | $148 |
| Medtronic, Inc. | 2 | $145 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Alnylam Pharmaceuticals Inc. | 2 | $50 |
Products named: WINREVAIR, REPATHA, LINQ II, OPSYNVI, LEQVIO, LifeVest, DUPIXENT, CAMZYOS.
Industry payments across NV — which companies pay providers there.
